At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 178 enrolled
Drug / intervention
Ginger +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomized Double-blind Placebo-controlled Trial on the Efficacy of Ginger in the Prevention of Abdominal Distention in Post Cesarean Section Patient
In Brief
A Phase 4 clinical trial evaluating Ginger and Placebo for Post Cesarean Section Patient. Completed, enrolled 178 participants.
Detailed Summary
The purpose of this study is to determine ginger is effective in the prevention of abdominal distention in post Cesarean section patient.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPost Cesarean Section Patient
Countries--
Collaborators--
Timeline
Phase 4CompletedFinished
2017201820192020202120222023202420252026
Enrollment StartJun 2016
First PostedJun 2016
Primary CompletionJun 2017
TodayJul 2026
First PostedJun 22, 2016
Enrollment StartJun 1, 2016
Primary CompletionJun 30, 2017
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 10.0 years ago
Interventions
Gingerdrug
Placebodrug